[Validation of a French version of the 16-item Prodromal Questionnaire (fPQ16) in adolescents and young adults seeking help].

Validation d’une version française du 16-items Prodromal Questionnaire (fPQ16) chez des adolescents et jeunes adultes consultant en psychiatrie.
At-risk mental state Detection Dépistage Détection Early intervention First episode psychosis Intervention précoce Premier épisode psychotique Prodromes Screening État mental à risque

Journal

L'Encephale
ISSN: 0013-7006
Titre abrégé: Encephale
Pays: France
ID NLM: 7505643

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 12 07 2019
revised: 15 11 2020
accepted: 17 11 2020
pubmed: 20 4 2021
medline: 15 12 2021
entrez: 19 4 2021
Statut: ppublish

Résumé

The duration of untreated psychosis has been largely associated with poor outcomes in psychosis. Actual diagnostic tools may be used by very specialized teams and need sustained evaluation. We present a French version of a self-report questionnaire: the 16-item Prodromal Questionnaire (fPQ16). Our objective was to evaluate its predictive value for an ultra-high-risk state (UHR) or psychosis. The population enrolled was consulting in a young adults and adolescents center in Sainte-Anne hospital, Paris, France. PQ16 had first been translated into French and independently back translated and validated by the original authors. Between November 2016 and May 2018, every C'JAAD consulting patient was proposed to fill in the fPQ16. Each patient was next evaluated with the French version of the comprehensive assessment of at-risk mental state (CAARMS), which detects UHR or psychosis. Statistical analysis of fPQ16 concurrent validity was performed using ROC curves. fPQ16 acceptability was studied by four additional questions especially designed for that purpose. One hundred participants were included. Mean age was 19.85years (SD 3.3 y). Fifty-eight percent of patients included were diagnosed with UHR (40%) or psychotic (18%) state after CAARMS evaluation. Mean score at fPQ16 was 5.7 (SD 3.8). Best cut-off score was 4 positive items, with excellent sensibility (91%) and correct specificity (60%). Positive predictive value of fPQ16 was 76%. Area under the curve was 0.85 (P<0.0001). fPQ16 showed good acceptability. fPQ16 had good screening performances in our population. Cut-off score was lower than in previous studies, but performances were equal or better. As a well-accepted and short questionnaire, the fPQ16 could be a great screening tool in primary care. A version with 18-items, including two items focused on thought content and disorganization that are missing in PQ16, is under evaluation.

Identifiants

pubmed: 33867141
pii: S0013-7006(21)00068-3
doi: 10.1016/j.encep.2020.11.009
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

547-553

Informations de copyright

Copyright © 2021 L'Encéphale, Paris. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

F Lejuste (F)

GHU psychiatrie et neuroscience, Sainte-Anne, France.

L Pedron (L)

GHU psychiatrie et neuroscience, Sainte-Anne, France.

E Bonnard (E)

GHU psychiatrie et neuroscience, Sainte-Anne, France; Inserm, laboratoire de physiopathologie des maladies psychiatriques, IPNP, U1266, université de Paris, institut de psychiatrie (CNRS GDR 3557), Paris, France.

M Urban (M)

GHU psychiatrie et neuroscience, Sainte-Anne, France.

Y Morvan (Y)

Inserm, laboratoire de physiopathologie des maladies psychiatriques, IPNP, U1266, université de Paris, institut de psychiatrie (CNRS GDR 3557), Paris, France; Laboratoire CLIPSYD, EA4430, UFR SPSE, université Paris Nanterre, 92000 Nanterre, France.

S Urben (S)

Service universitaire de psychiatrie de l'enfant et de l'adolescent, département de psychiatrie, centre hospitalier universitaire vaudois, Lausanne, Suisse.

R Gaillard (R)

GHU psychiatrie et neuroscience, Sainte-Anne, France.

P Conus (P)

Service de psychiatrie générale, département de psychiatrie, centre hospitalier universitaire vaudois, Lausanne, Suisse.

M-O Krebs (MO)

GHU psychiatrie et neuroscience, Sainte-Anne, France; Inserm, laboratoire de physiopathologie des maladies psychiatriques, IPNP, U1266, université de Paris, institut de psychiatrie (CNRS GDR 3557), Paris, France. Electronic address: mo.krebs@ghu-paris.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH